Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 29 of 29 entries
Sorted by: Best Match Show Resources per page
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.

The Lancet. Oncology

Tammemägi MC, Ruparel M, Tremblay A, Myers R, Mayo J, Yee J, Atkar-Khattra S, Yuan R, Cressman S, English J, Bedard E, MacEachern P, Burrowes P, Quaife SL, Marshall H, Yang I, Bowman R, Passmore L, McWilliams A, Brims F, Lim KP, Mo L, Melsom S, Saffar B, Teh M, Sheehan R, Kuok Y, Manser R, Irving L, Steinfort D, McCusker M, Pascoe D, Fogarty P, Stone E, Lam DCL, Ng MY, Vardhanabhuti V, Berg CD, Hung RJ, Janes SM, Fong K, Lam S.
PMID: 34902336
Lancet Oncol. 2022 Jan;23(1):138-148. doi: 10.1016/S1470-2045(21)00590-8. Epub 2021 Dec 11.

BACKGROUND: Lung cancer is a major health problem. CT lung screening can reduce lung cancer mortality through early diagnosis by at least 20%. Screening high-risk individuals is most effective. Retrospective analyses suggest that identifying individuals for screening by accurate...

Cite
Tammemägi MC, Ruparel M, Tremblay A, et al. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 2021;23(1):138-148doi: 10.1016/S1470-2045(21)00590-8.
Tammemägi, M. C., Ruparel, M., Tremblay, A., Myers, R., Mayo, J., Yee, J., Atkar-Khattra, S., Yuan, R., Cressman, S., English, J., Bedard, E., MacEachern, P., Burrowes, P., Quaife, S. L., Marshall, H., Yang, I., Bowman, R., Passmore, L., McWilliams, A., Brims, F., Lim, K. P., Mo, L., Melsom, S., Saffar, B., Teh, M., Sheehan, R., Kuok, Y., Manser, R., Irving, L., Steinfort, D., McCusker, M., Pascoe, D., Fogarty, P., Stone, E., Lam, D. C. L., Ng, M. Y., Vardhanabhuti, V., Berg, C. D., Hung, R. J., Janes, S. M., Fong, K., & Lam, S. (2022). USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. The Lancet. Oncology, 23(1), 138-148. https://doi.org/10.1016/S1470-2045(21)00590-8
Tammemägi, Martin C, et al. "USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study." The Lancet. Oncology vol. 23,1 (2022): 138-148. doi: https://doi.org/10.1016/S1470-2045(21)00590-8
Tammemägi MC, Ruparel M, Tremblay A, Myers R, Mayo J, Yee J, Atkar-Khattra S, Yuan R, Cressman S, English J, Bedard E, MacEachern P, Burrowes P, Quaife SL, Marshall H, Yang I, Bowman R, Passmore L, McWilliams A, Brims F, Lim KP, Mo L, Melsom S, Saffar B, Teh M, Sheehan R, Kuok Y, Manser R, Irving L, Steinfort D, McCusker M, Pascoe D, Fogarty P, Stone E, Lam DCL, Ng MY, Vardhanabhuti V, Berg CD, Hung RJ, Janes SM, Fong K, Lam S. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 2022 Jan;23(1):138-148. doi: 10.1016/S1470-2045(21)00590-8. Epub 2021 Dec 11. PMID: 34902336.
Copy Download .nbib Format: NLM
Mirror neuron activity is no proof for action understanding.

Frontiers in human neuroscience

Steinhorst A, Funke J.
PMID: 24904373
Front Hum Neurosci. 2014 May 22;8:333. doi: 10.3389/fnhum.2014.00333. eCollection 2014.

No abstract available.

Cite
Steinhorst A, Funke J. Mirror neuron activity is no proof for action understanding. Front Hum Neurosci. 2014;8:333doi: 10.3389/fnhum.2014.00333.
Steinhorst, A., & Funke, J. (2014). Mirror neuron activity is no proof for action understanding. Frontiers in human neuroscience, 8333. https://doi.org/10.3389/fnhum.2014.00333
Steinhorst, Alina, and Funke, Joachim. "Mirror neuron activity is no proof for action understanding." Frontiers in human neuroscience vol. 8 (2014): 333. doi: https://doi.org/10.3389/fnhum.2014.00333
Steinhorst A, Funke J. Mirror neuron activity is no proof for action understanding. Front Hum Neurosci. 2014 May 22;8:333. doi: 10.3389/fnhum.2014.00333. eCollection 2014. PMID: 24904373; PMCID: PMC4033129.
Copy Download .nbib Format: NLM
Automated assessment of functional lung imaging with .

EJNMMI physics

McIntosh L, Jackson P, Hardcastle N, Bressel M, Kron T, Callahan JW, Steinfort D, Bucknell N, Hofman MS, Siva S.
PMID: 33677692
EJNMMI Phys. 2021 Mar 07;8(1):23. doi: 10.1186/s40658-021-00375-6.

PURPOSE: Functional lung mapping from GaMETHODS: Sixty-six patients recruited from a prospective clinical trial underwent both V/Q PET/CT imaging and PFT analysis before treatment. PET images were normalised using an iterative histogram analysis technique to account for tracer hotspots...

Cite
McIntosh L, Jackson P, Hardcastle N, et al. Automated assessment of functional lung imaging with . EJNMMI Phys. 2021;8(1):23doi: 10.1186/s40658-021-00375-6.
McIntosh, L., Jackson, P., Hardcastle, N., Bressel, M., Kron, T., Callahan, J. W., Steinfort, D., Bucknell, N., Hofman, M. S., & Siva, S. (2021). Automated assessment of functional lung imaging with . EJNMMI physics, 8(1), 23. https://doi.org/10.1186/s40658-021-00375-6
McIntosh, Lachlan, et al. "Automated assessment of functional lung imaging with ." EJNMMI physics vol. 8,1 (2021): 23. doi: https://doi.org/10.1186/s40658-021-00375-6
McIntosh L, Jackson P, Hardcastle N, Bressel M, Kron T, Callahan JW, Steinfort D, Bucknell N, Hofman MS, Siva S. Automated assessment of functional lung imaging with . EJNMMI Phys. 2021 Mar 07;8(1):23. doi: 10.1186/s40658-021-00375-6. PMID: 33677692; PMCID: PMC7937580.
Copy Download .nbib Format: NLM
Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl.

GMS ophthalmology cases

Steinhorst NA, Spitzer M, Skevas C.
PMID: 32884887
GMS Ophthalmol Cases. 2020 Aug 06;10:Doc33. doi: 10.3205/oc000160. eCollection 2020.

No abstract available.

Cite
Steinhorst NA, Spitzer M, Skevas C. Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl. GMS Ophthalmol Cases. 2020;10:Doc33doi: 10.3205/oc000160.
Steinhorst, N. A., Spitzer, M., & Skevas, C. (2020). Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl. GMS ophthalmology cases, 10Doc33. https://doi.org/10.3205/oc000160
Steinhorst, Nils Alexander, et al. "Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl." GMS ophthalmology cases vol. 10 (2020): Doc33. doi: https://doi.org/10.3205/oc000160
Steinhorst NA, Spitzer M, Skevas C. Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl. GMS Ophthalmol Cases. 2020 Aug 06;10:Doc33. doi: 10.3205/oc000160. eCollection 2020. PMID: 32884887; PMCID: PMC7452948.
Copy Download .nbib Format: NLM
Year in review 2017: Interventional pulmonology, lung cancer, pleural disease and respiratory infections.

Respirology (Carlton, Vic.)

Yarmus L, Nguyen PT, Montemayor K, Jennings M, Bade B, Shafiq M, Silvestri G, Steinfort D.
PMID: 29641840
Respirology. 2018 Jun;23(6):628-635. doi: 10.1111/resp.13306. Epub 2018 Apr 11.

No abstract available.

Cite
Yarmus L, Nguyen PT, Montemayor K, et al. Year in review 2017: Interventional pulmonology, lung cancer, pleural disease and respiratory infections. Respirology. 2018;23(6):628-635doi: 10.1111/resp.13306.
Yarmus, L., Nguyen, P. T., Montemayor, K., Jennings, M., Bade, B., Shafiq, M., Silvestri, G., & Steinfort, D. (2018). Year in review 2017: Interventional pulmonology, lung cancer, pleural disease and respiratory infections. Respirology (Carlton, Vic.), 23(6), 628-635. https://doi.org/10.1111/resp.13306
Yarmus, Lonny, et al. "Year in review 2017: Interventional pulmonology, lung cancer, pleural disease and respiratory infections." Respirology (Carlton, Vic.) vol. 23,6 (2018): 628-635. doi: https://doi.org/10.1111/resp.13306
Yarmus L, Nguyen PT, Montemayor K, Jennings M, Bade B, Shafiq M, Silvestri G, Steinfort D. Year in review 2017: Interventional pulmonology, lung cancer, pleural disease and respiratory infections. Respirology. 2018 Jun;23(6):628-635. doi: 10.1111/resp.13306. Epub 2018 Apr 11. PMID: 29641840.
Copy Download .nbib Format: NLM
Showing 25 to 29 of 29 entries